Download video

Dr. Nicholas Vogelzang Discusses Sequencing Abiraterone and Enzalutamide

803 views

OncLive

11 years ago

Dr. Nicholas Vogelzang Discusses Sequencing Abiraterone and Enzalutamide

Dr. Nicholas Vogelzang Discusses Sequencing Abiraterone and Enzalutamide

Dr. Nicholas Vogelzang Discusses Sequencing Abiraterone and Enzalutamide
1:53
Dr. Nicholas Vogelzang Discusses Sequencing Abiraterone and Enzalutamide
by OncLive
Dr. Pal on Sequencing Abiraterone and Enzalutamide in mCRPC
1:12
Dr. Pal on Sequencing Abiraterone and Enzalutamide in mCRPC
by Targeted Oncology
Nicholas J. Vogelzang, MD, FASCO, FACP, on identifying the best patients for Zytiga versus Xtandi
0:59
Nicholas J. Vogelzang, MD, FASCO, FACP, on identifying the best patients for Zytiga versus Xtandi
by OBRoncology
Dr. Nicholas Vogelzang Discusses Radium-223 in Prostate Cancer
1:49
Dr. Nicholas Vogelzang Discusses Radium-223 in Prostate Cancer
by OncLive
Treatment sequencing in mCRPC: cabazitaxel vs. abiraterone or enzalutamide
1:52
Treatment sequencing in mCRPC: cabazitaxel vs. abiraterone or enzalutamide
by VJOncology
Dr. Nicholas Vogelzang Discusses Latest Advances in Prostate Cancer
2:31
Dr. Nicholas Vogelzang Discusses Latest Advances in Prostate Cancer
by OncLive
Nicholas Vogelzang, MD, FASCO, FACP, describes the role of PARP inhibitors advanced prostate cancer
6:19
Nicholas Vogelzang, MD, FASCO, FACP, describes the role of PARP inhibitors advanced prostate cancer
by OBRoncology
Dr. Nicholas Vogelzang Discusses PSMA ADC in Prostate Cancer
2:55
Dr. Nicholas Vogelzang Discusses PSMA ADC in Prostate Cancer
by Targeted Oncology
Dr. Vogelzang Discusses the Addition of Chemotherapy to ADT in Men With Prostate Cancer
3:07
Dr. Vogelzang Discusses the Addition of Chemotherapy to ADT in Men With Prostate Cancer
by OncLive
Comparing the Second Generation Hormone Therapies | Ask a Prostate Expert, Mark Scholz, MD
7:00
Comparing the Second Generation Hormone Therapies | Ask a Prostate Expert, Mark Scholz, MD
by Prostate Cancer Research Institute
Zytiga Patient Stories
8:49
Zytiga Patient Stories
by Prostate Oncology Specialists
Advanced Prostate Cancer
1:13:14
Advanced Prostate Cancer
by University of California Television (UCTV)
What to do with the post-abiraterone\/-enzalutamide patient? - Nicholas J. Vogelzang
15:42
What to do with the post-abiraterone\/-enzalutamide patient? - Nicholas J. Vogelzang
by Genitourinary Cancers
Head-to-head: tolerability of enzalutamide vs. abiraterone acetate for metastatic CRPC
2:13
Head-to-head: tolerability of enzalutamide vs. abiraterone acetate for metastatic CRPC
by VJOncology
Nicholas J. Vogelzang, MD, on where chemotherapy fits into treatment for prostate cancer
1:41
Nicholas J. Vogelzang, MD, on where chemotherapy fits into treatment for prostate cancer
by OBRoncology
The use of abiraterone and enzalutamide against CRPC
8:12
The use of abiraterone and enzalutamide against CRPC
by ecancer
2013 OncPrac Summit: Nicholas Vogelzang on how he treats metastic prostate cancer
5:01
2013 OncPrac Summit: Nicholas Vogelzang on how he treats metastic prostate cancer
by MDedge: news and insights for busy physicians
Dr. Charles Ryan Discusses Abiraterone and Enzalutamide for mCRPC
2:09
Dr. Charles Ryan Discusses Abiraterone and Enzalutamide for mCRPC
by Targeted Oncology
Oral Hormonal Agents for Metastatc Castration-Resistant Prostate Cancer
5:37
Oral Hormonal Agents for Metastatc Castration-Resistant Prostate Cancer
by OncLive
Dr. Vogelzang Discusses PROSPECT Trial for Prostate Cancer
1:34
Dr. Vogelzang Discusses PROSPECT Trial for Prostate Cancer
by OncLive
Dr. Attard on Abiraterone
0:53
Dr. Attard on Abiraterone
by Prostate Cancer Foundation
Radium-223 Administration and Effective Imaging Studies
4:06
Radium-223 Administration and Effective Imaging Studies
by Targeted Oncology
Dr. Crawford on Abiraterone Versus Enzalutamide in Prostate Cancer
0:59
Dr. Crawford on Abiraterone Versus Enzalutamide in Prostate Cancer
by OncLive